Mineral exposures in pediatric sarcoidosis

N. Nathan (Paris, France), M. Montagne (Paris, France), O. Macchi (Paris, France), P. Rosental (Paris, France), S. Chauveau (Bobigny, France), F. Jeny (Bobigny, France), L. Sesé (Bobigny, France), R. Abou Taam (Paris, France), J. Brouard (Caen, France), M. Catinon (Villeurbanne, France), C. Chapelon-Abric (Paris, France), F. Cohen Aubart (Paris, France), C. Delacourt (Paris, France), C. Delestrain (Créteil, France), A. Deschildre (Lille, France), A. Dossier (Paris, France), R. Epaud (Créteil, France), J. Haroche (Paris, France), V. Houdouin (Paris, France), D. Israel-Biet (Paris, France), K. Juvin (Paris, France), S. Le Jeune (Bobigny, France), F. Lionnet (Paris, France), U. Meinzer (Paris, France), M. Mittaine (Toulouse, France), H. Nunes (Bobigny, France), S. Mattioni (Paris, France), J. Naccache (Paris & Suresnes, France), M. Odièvre (Paris, France), M. Vincent (Villeurbanne, France), A. Clement (Paris, France), D. Valeyre (Paris, France), C. Cavalin (Paris & Noisy le Grand, France)

Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Session: Better understanding of sarcoidosis: new keys
Session type: Oral Presentation
Number: 3977

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Nathan (Paris, France), M. Montagne (Paris, France), O. Macchi (Paris, France), P. Rosental (Paris, France), S. Chauveau (Bobigny, France), F. Jeny (Bobigny, France), L. Sesé (Bobigny, France), R. Abou Taam (Paris, France), J. Brouard (Caen, France), M. Catinon (Villeurbanne, France), C. Chapelon-Abric (Paris, France), F. Cohen Aubart (Paris, France), C. Delacourt (Paris, France), C. Delestrain (Créteil, France), A. Deschildre (Lille, France), A. Dossier (Paris, France), R. Epaud (Créteil, France), J. Haroche (Paris, France), V. Houdouin (Paris, France), D. Israel-Biet (Paris, France), K. Juvin (Paris, France), S. Le Jeune (Bobigny, France), F. Lionnet (Paris, France), U. Meinzer (Paris, France), M. Mittaine (Toulouse, France), H. Nunes (Bobigny, France), S. Mattioni (Paris, France), J. Naccache (Paris & Suresnes, France), M. Odièvre (Paris, France), M. Vincent (Villeurbanne, France), A. Clement (Paris, France), D. Valeyre (Paris, France), C. Cavalin (Paris & Noisy le Grand, France). Mineral exposures in pediatric sarcoidosis. 3977

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Paediatric sarcoidosis
Source: Eur Respir Monogr 2022; 96: 285-294
Year: 2022


Detection and documentation of asbestosis and mineral pneumoconioses in individuals and populations
Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma
Year: 2004

Progression of Idiopathic Pulmonary Fibrosis in patients with past occupational exposure to dusts
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017

Effects of air pollution on asthma and respiratory symptoms in schoolchildren
Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors
Year: 2014


Organic dust toxic syndrome caused by occupational exposure to shrimpshell powder
Source: International Congress 2015 – Occupational and environmental exposure assessment and biomarkers
Year: 2015


Prevalence of beryllium sensitization in patients diagnosed with sarcoidosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Profiling of hypersensitivity pneumonitis diagnosed at a UK specialist service for ILD and occupational lung diseases
Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways
Year: 2018



Mineral density of bone tissue in sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 232s
Year: 2003

Acute exacerbation of bronchiectasis – Experience of a Tunisian pulmonology department
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Inorganic exposome in pediatric sarcoidosis: The PEDIASARC study
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


Lung function in elderly former uranium miners with silicosis
Source: Eur Respir J 2002; 20: Suppl. 38, 128s
Year: 2002

Long-term FEV1 decline and bone mineral density in asthma
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014

Respiratory tract deposition of inhaled wood smoke particle in healthy volunteers and patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Indoor and outdoor pollutants: ventilation, sprays, diesel particles, asthma and COPD
Year: 2013


Air pollution exposure during pregnancy and infancy and childhood asthma
Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases
Year: 2014

Clinico-pathological profile of adult bronchiectasis patients at a North Indian teaching hospital
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Respiratory surveillance in mineral dust-exposed workers
Source: Breathe, 16 (1) 190632; 10.1183/20734735.0362-2019
Year: 2020



Ocular manifestations of sarcoidosis in Turkish patients
Source: Eur Respir J 2003; 22: Suppl. 45, 440s
Year: 2003

Management of cardiac sarcoidosis
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020